Total Return tumbles back to just 61% overall

Covid Vaccine Stocks slip back to lowest point - a return of just 61% overall for all stocks. Every stock in the index lost ground this week except Immunity Bio.

 

Broad-based sell-off to end the week - 24 stocks dropped.

Another broad-based sell-off with 24 stocks dropping and only three gaining.

The overall average was a significant loss of 3.2%.

The biggest loser was Generex falling 20%. Tonix dropped 8% and PDS dropped 7%. 

 

Unanimous Sell-off Down 5.5% on average overall

Devastating Unanimous Sell-OFF!! 

5.5% LOSS OVERALL. 

 

Big broad-based gains for Covid Vaccine Stocks - Immunity Bio jumps 22%

Rocketing upwards on February 15. A real strong broad-based move upwards lead by Immunity Bio which moved up 22%. There were fully 24 winners and only three losers today. 

The next strongest gainers were Novavax and Vaxart with 9% gains.

Vir, Ocugen and VBI all picked up 7%. 

 

Heavy selling to start the week - Big Three hit hard.

 

Heavy selling to start the week. Overall there was a loss of 3.5%. There were 22 stocks who lost ground and five that gained.

The big three took the biggest hit. Moderna fell just under 12%, Novavax fell 11% and BioNTech fell 10%. Arcturus fell 7%. 

CureVac, Vir, Sorrento and Tonix fell 6%. 

OncoSec and iBio picked up 5%. 

Covid Vaccine Stocks move moderately higher.

Covid Vaccine Stocks bounce off the lows of January with total returns edging up to 72%.

PDS jumps by 117% in total returns and into third spot.

 

Week finishes with a 2.3% drop

Stocks close the week slipping another 2.3%. There were no double digit losses but only six that gained ground with 21 losers.

Adaptive lead on the downside with a loss of 8%. Inovio lost 6%. Emergent lead on the upside with a gain of 5%.